A Phase 1/2a Study of LON002 in Subjects With Advanced Solid Tumours
Clinical trial NCT02263950 · UNKNOWN
Trial details
- NCT number
- NCT02263950
- Sponsor
- LondonPharma Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2016-10-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.